J. M. Arteagoitia

[Hospital resources and myocardial infarction case fatality. The IBERICA study].

R. Elosua, J. Marrugat, C. Navarro, 2004, Revista espanola de cardiologia.

Socio‐economic inequalities in the prevalence of Type 2 diabetes, cardiovascular risk factors and chronic diabetic complications in the Basque Country, Spain

S. Esnaola, J. L. Rodriguez, J. M. Arteagoitia, 2005, Diabetic medicine : a journal of the British Diabetic Association.

A Novel Form of Human Disease

M. Pancorbo, J. Zarranz, R. Juste, 2013 .

A novel form of human disease with a protease-sensitive prion protein and heterozygosity methionine/valine at codon 129: Case report

I. Ferrer, M. D. de Pancorbo, J. Zarranz, 2010, BMC neurology.

Familial Prion Diseases in the Basque Country (Spain)

J. Zarranz, M. Fernández-Martínez, J. Martí-Massó, 2004, Neuroepidemiology.

Coexistence of protease sensitive and resistant prion protein in 129VV homozygous sporadic Creutzfeldt–Jakob disease: a case report

I. Ferrer, A. L. de Munain, J. Zarranz, 2012, Journal of Medical Case Reports.

Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case-control studies, Spain, season 2009-2010

T. Vega, F. Pozo, I. Casas, 2011, BMC public health.

Development of a prediction model for fatal and non-fatal coronary heart disease and cardiovascular disease in patients with newly diagnosed type 2 diabetes mellitus: The Basque Country Prospective Complications and Mortality Study risk engine (BASCORE)

I. Irigoien, J. Altzibar, J. M. Arteagoitia, 2014, Diabetologia.

Acute flaccid paralysis (AFP) surveillance: challenges and opportunities from 18 years’ experience, Spain, 1998 to 2015

D. Castrillejo, N. Torner, M. G. Cenoz, 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[Analysis with the propensity score of the association between likelihood of treatment and event of interest in observational studies. An example with myocardial reperfusion].

J. Marrugat, C. Navarro, J. Sala, 2005, Revista espanola de cardiologia.

Smoking and myocardial infarction case-fatality: hospital and population approach

J. Marrugat, C. Navarro, J. Sala, 2007, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

Escalas de cálculo del riesgo cardiovascular para pacientes con diabetes. ¿Qué son y de qué nos sirven?

J. M. Arteagoitia, Fernando González-Carril, J. A. Piniés, 2015 .

Dose-response association of physical activity with acute myocardial infarction: do amount and intensity matter?

J. Marrugat, M. Fiol, E. Aldasoro, 2013, Preventive medicine.

[Public health surveillance: a pressing need].

M. Pollán, X. Hervada, J. M. Arteagoitia, 2017, Gaceta sanitaria.

Effectiveness of a Meningococcal Group B Vaccine (4CMenB) in Children.

J. Castilla, A. Barricarte, J. Vázquez, 2023, The New England journal of medicine.